Found 28 matching trials
Bioavailability Study Of PF-06651600 In Healthy Subjects
PHASE1PF-06651600 is being developed for treatment of inflammatory bowel disease....
Location
Pfizer Clinical Research Unit
A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults
PHASE1A phase I, single dose study to test two forms of pediatric ritlecitinib co...
Location
New Haven Clinical Research Unit
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
PHASE2This is a Phase 2a, randomized, double blind, parallel group, multicenter s...
Location
University of Alabama at Birmingham, Dermatology at the Whitaker Clinic
A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
PHASE1The purpose of this study is to compare if three forms of study medicine (c...
Location
Pfizer Clinical Research Unit - Brussels
Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
PHASE1This is a Phase 1, 2-period, multiple-dose, open-label, single fixed sequen...
Location
New Haven Clinical Research Unit
Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.
PHASE1The study will be conducted as a Phase 1, open-label, single-dose, randomiz...
Location
Research Centers of America ( Hollywood )
Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids
PHASE1This is a Phase 1, randomized, 2 way crossover, open-label study of the eff...
Location
Quotient Sciences Screening Office
ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ
PHASE1The current study will estimate any inhibitive or inductive effect of PF-06...
Location
Pfizer New Haven Clinical Research Unit
PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS
PHASE1This is an open label, single arm study in healthy Chinese male and/or fema...
Location
Peking University Third Hospital
A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS
PHASE1The purpose of this study is to evaluate the potential pharmacokinetic (PK)...
Location
Pfizer New Haven Clinical Research Unit